Medite Cancer Diagnostics

MDIT · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed · Oct 5, 9:38 AM ET

No price history for this range.

About MDIT

MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The company is headquartered in Chicago, Illinois. The firm also develops, manufactures, markets, and sells MEDITE branded products (instruments and consumables), in the areas of histology and cytology. The firm has a distribution network to over 80 countries and a range of products for anatomic pathology, histology and cytology laboratories available for sale. The Company’s subsidiaries consist of MEDITE Enterprise, Inc., MEDITE GmbH, Burgdorf, Germany and MEDITE Lab Solutions Inc.

Employees: 0
Headquarters: Chicago, Illinois
Listed: Oct 27, 1993
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: medite-group.com

Leadership

Medite Cancer Diagnostics executives
Name	Title	Since	Age
William Lewis	—	—	45
Michaela Ott	—	2014	55
Jeff Rencher	—	—	53
Gregory Fortunoff	—	—	51
John Abeles	—	—	75
Joel Kanter	—	—	62
Alexander Milley	—	—	69

Similar companies

Companies in the same industry as Medite Cancer Diagnostics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.